FINWIRES · TerminalLIVE
FINWIRES

Wedbush Downgrades Cross Country Healthcare to Neutral From Outperform, Cuts Price Target to $13.25 From $15 Amid Knox Lane Deal

By

-- Cross Country Healthcare (CCRN) has an average rating of hold and mean price target of $11.67, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Asia

Nila Spaces Posts Higher Consolidated Profit in Fiscal Q4

Nila Spaces (NSE:NILASPACES, BOM:542231) recorded a consolidated net profit attributable to owners of 92 million Indian rupees in the fiscal fourth quarter, almost double compared with 47.2 million rupees a year ago, according to an Indian bourse filing on Thursday.Earnings per share for the quarter ended March 31 climbed to 0.24 rupees from 0.12 rupees a year earlier.The real estate company's revenue from operations in fiscal Q4 increased year on year to 498.0 million rupees from 397.6 million rupees.

$BOM:542231$NSE:NILASPACES
Australia

Warby Parker Shares Rise After Higher Q1 Net Revenue Posted

Warby Parker (WRBY) shares were up more than 25% in early trading on Thursday after the company posted higher Q1 net revenue.The company reported Q1 earnings Thursday of $0.03 per diluted share, unchanged from a year earlier.Analysts polled by FactSet expected $0.05.Net revenue for the quarter ended March 31 was $242.4 million, up from $223.8 million a year earlier.Analysts expected revenue of $239.4 million.The company reaffirmed its full-year 2026 net revenue guidance of $959 million to $976 million. Analysts expect revenue of $980.8 million.Price: $26.01, Change: $+4.00, Percent Change: +18.17%

$WRBY
Australia

Genesis Energy Shares Gain After Q1 Net Loss Narrows, Revenue Rises

Genesis Energy (GEL) shares were marginally higher in early trading on Thursday after the company reported a Q1 net loss from continuing operations of $0.06 per diluted unit, narrower than a loss of $0.60 a year earlier.Analysts' estimates were not readily available for comparison.Revenue for the quarter ended March 31 was $446.6 million, up from $398.3 million a year earlier.Price: $16.45, Change: $+0.07, Percent Change: +0.46%

$GEL